Two cytochrome P450 (P450) cDNAs involved in the biosynthesis of berberine, an antimicrobial benzylisoquinoline alkaloid, were isolated from cultured Coptis japonica cells and characterized. A sequence analysis showed that one C. japonica P450 (designated CYP719) belonged to a novel P450 family. Further, heterologous expression in yeast confirmed that it had the same activity as a methylenedioxy bridge-forming enzyme (canadine synthase), which catalyzes the conversion of (
enzymes because of the large number of compounds represented and their reaction diversity, e.g. hydroxylation, alkene epoxidation, dealkylation, and oxidative deamination (1) . For example, liver microsomal P450 is well known to exist in multiple forms and to play important roles in the detoxification of xenobiotics (2) . Although the reactions in plants that involve P450s have not been well studied because of their low abundance and the difficulty of biochemical characterization, recent studies have shown that many biochemical reactions in plants are catalyzed by P450s (3) .
In the biosynthesis of antimicrobial benzylisoquinoline (berberine) or benzophenanthridine (sanguinarine) alkaloids, several P450 reactions have been reported ( Fig. 1 ) (4 -8) . A P450 (CYP80B1) catalyzes hydroxylation, i.e. the conversion of (S)-N-methylcoclaurine to (S)-3Ј-hydroxy-N-methylcoclaurine, and the cDNA has been isolated from California poppy (Eschscholzia californica) (5) . Other P450 reactions include methylenedioxy bridge formation (6 -8) ; e.g. the conversion of (S)-tetrahydrocolumbamine ((S)-THC) to (S)-tetrahydroberberine ((S)-THB, (S)-canadine) has been studied in part by using microsomal fractions of Thalictrum tuberosum cells (7) . Two other methylenedioxy bridge-forming reactions from (S)-scoulerine via (S)-cheilanthifoline to (S)-stylopine have been partially characterized in California poppy (8) . Because Coptis japonica cells produce berberine and coptisine, which is the oxidized form of (S)-stylopine, we speculated that the cells of this plant may also exhibit these methylenedioxy bridge-forming reactions along with the CYP80B hydroxylation reaction (Fig. 1) .
Whereas previous reports have indicated that biosynthetic enzymes involved in berberine/(S)-stylopine biosynthesis have relatively strict substrate specificity (5, (7) (8) (9) (10) (11) (12) , many P450s, especially those involved in the detoxification of xenobiotics, are known to have relatively broad substrate specificity (2) . Therefore, we hypothesized that all of the methylenedioxy bridge-forming reactions in berberine/coptisine biosynthesis in C. japonica might be catalyzed by a single P450, although with different reactivities. To clarify this point, we tried to isolate a methylenedioxy bridge-forming P450 cDNA from cultured C. japonica 156-1 cells.
Because cultured C. japonica 156-1 cells produce large amounts of berberine and coptisine (13) , we speculated that the desired P450 involved in berberine/coptisine biosynthesis would be highly expressed in these cells. Based on this idea, we amplified cDNA fragments specific to eukaryotic P450s from a cDNA library prepared from cultured C. japonica 156-1 cells. Next, using these cDNA fragments, we isolated full-length cDNAs, determined the primary structures, and produced recombinant proteins in a yeast expression system to identify their biochemical activity. The data indicated that an isolated cDNA encoded a novel P450 that showed methylenedioxy bridge-forming activity to convert (S)-THC to (S)-THB. The kinetic parameters and substrate specificity were determined to clarify whether this P450 may function in other biosynthetic steps and to evaluate the metabolic regulation of berberine biosynthesis by this enzyme. 
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Plant Material-Coptis (C. japonica Makino var. Dissecta (Yatabe) Nakai) plants were obtained from the herbal garden of Takeda Chemical Industries. The original cultured cells were induced from rootlets of C. japonica, and a cell line (156-1) with high berberine productivity was established by small cell aggregate selection and subcultured as described previously (13) . Fourteen-day-old cultured cells were harvested and used for the extraction of mRNA.
Chemicals-Berberine sulfate was purchased from Tokyo Kasei Kogyo Co., Ltd. (S)-Coclaurine was a gift from Dr. N. Nagakura of Kobe Women's College of Pharmacy, Japan. (S)-N-Methylcoclaurine was a gift from Dr. Y. Sugimoto of Tottori University, Japan. (S)-Scoulerine, (R,S)-reticuline, (R,S)-norreticuline, and (R,S)-6-O-methylnorlaudanosoline were gifts from Mitsui Petrochemical Industries, Ltd. (S)-Tetrahydrocolumbamine was prepared from (S)-scoulerine by using recombinant S-adenosyl-L-methionine:scoulerine 9-O-methyltransferase (SMT) expressed in Escherichia coli as described previously (14) . (R,S)-Tetrahydroberberine was prepared from berberine as described previously (15) . Columbamine was synthesized and purified from berberine by two-step reactions according to the method of Cava and Reed (16, 17) . Ketoconazole was kindly donated by Dr. Y. Aoyama of Sohka University, Japan.
Amplification of Cytochrome P450 cDNA Fragments from a cDNA Library of Cultured C. japonica Cells-A cDNA library of cultured C. japonica cells was prepared with a ZAP-cDNA synthesis kit and Gigapack II Gold packaging extract (Stratagene, La Jolla, CA) as described previously (14) . This cDNA library was used as a template for amplification of P450 cDNA fragments. Two pairs of degenerate primers were designed for the sequences conserved among eukaryotic P450s (18) . One pair was the F1 primer (5Ј-MTIMMITAYITIHVIRYIRTIIKI-WAVGA-3Ј) for the helix K region and the R1 primer (5Ј-CCIRSRCAR-MYYCTISKICCIVMICYRAAIGG-3Ј) for the heme-binding region (where M ϭ A or C, I ϭ inosine, Y ϭ C or T, H ϭ A or T or C, V ϭ A or C or G, R ϭ A or G, K ϭ T or G, W ϭ A or T, S ϭ C or G). The other pair was the F2 primer (5Ј-GCGAATTCRYIRTIIKIWAVGARIYIYTIMG-3Ј) for the helix K region and the R2 primer (5Ј-GCGAATTCAVRAAYCK-HWYIGGIIIRAA-3Ј) for the aromatic region. In the first PCR, the F1 and R1 primers were used for amplification of P450 partial cDNAs under the following PCR conditions: denaturation, 4 min at 94°C; initial 5 cycles, 1 min at 94°C, 1 min at 37°C, 2 min at 37°C to 72°C, and 1 min at 72°C; additional 35 cycles, 1 min at 94°C, 1 min at 37°C, and 1 min at 72°C. Amplified PCR products at about 280 bp were used as the template for the second PCR using the F2 and R2 primers under the same PCR conditions as in the first PCR. The resultant PCR products at about 200 bp were subcloned into pBluescript II SKϪ (Stratagene) and sequenced in a DSQ-1000 automated sequencer (Shimadzu, Kyoto, Japan) with a Thermo Sequenase® fluorescent labeled primer cycle sequencing kit (Amersham Biosciences). Sequenced clones showed two different sequences that were obviously homologous to known P450s.
Screening of Cytochrome P450 cDNAs from a cDNA Library-The above cDNA library was used to screen full-length cDNAs of P450. The second PCR products at about 200 bp were used as hybridization probes. The first screening of ϳ200,000 plaque-forming units yielded 123 positive signals, and the third screening yielded 40 independent phages. PCR with the M13-Rv primer and R1 primer revealed that these phages were mixtures of clones with cDNAs of two different lengths; i.e. about 1.7 and 0.8 kb. These cDNA inserts of the plasmid vector (pBluescript SKϪ) were excised in vivo with a ZAP-cDNA synthesis kit and then used for transformation to E. coli XL1-Blue (Stratagene). The nucleotide sequences of the inserts were determined as described above.
5Ј-Rapid Amplification of cDNA Ends (RACE)-A double-stranded cDNA library with an adaptor sequence at both ends was synthesized from poly(A) ϩ RNA, which was prepared from cultured C. japonica cells, with a Marathon cDNA Amplification Kit (Clontech). 5Ј-RACE was carried out with an adaptor primer (5Ј-CCATCCTAATACGACT-CACTATAGGGC-3Ј) and a gene-specific primer (5Ј-CATGTAGTGGTA- GAGGAAGTACTGTCC-3Ј). The amplified fragments at about 900 bp were subcloned into pT7Blue T-Vector (Novagen, Madison, WI) and sequenced as described above. Alignment Analysis-The predicted protein sequences were aligned using ClustalW (19, 20) and Boxshade (www.ch.embnet.org/software/ BOX_form.html). ClustalW was also used to calculate the phylogenetic tree using the neighbor-joining method (21) .
RNA Blot Analysis-RNA was isolated from cultured C. japonica 156-1 cells and C. japonica plant tissues. Cultured C. japonica cells were harvested after 12 days of culture, when biosynthetic activity was high, to extract total RNA. Freshly harvested C. japonica plants were separated into leaves, petioles, rhizomes, and roots and then stored in liquid nitrogen until the extraction of total RNA. Total RNA was prepared as described previously (22) . Ten g of total RNA was separated on a 1.2% denaturing formaldehyde-agarose gel and blotted onto a Hybond-Nϩ nylon membrane (Amersham Biosciences) with 20ϫ SSC (333 mM sodium chloride/sodium citrate) as a transfer buffer according to the standard procedure (23). The 32 P-labeled probes were synthesized by random priming using a Random Primed DNA Labeling Kit (Roche Applied Science). Four types of probes were synthesized, corresponding to the following fragments: 3Ј-fragment of CYP719 cDNA, 3Ј-fragment of CYP80B2 cDNA, 5Ј-fragment of S-adenosyl-L-methionine:norcoclaurine 6-O-methyltransferase (6-OMT) cDNA (11) , and 5Ј-fragment of S-adenosyl-L-methionine:3Ј-hydroxy-N-methylcoclaurine 4Ј-O-methyltransferase (4Ј-OMT) cDNA (11) . Hybridization was carried out for 16 h at 60°C with 6ϫ SSC, 5ϫ Denhardt's reagent, 0.1% SDS, 100 g/ml of denatured salmon sperm DNA, and the labeled probes. After hybridization, the membrane was washed once for 10 min with 1ϫ SSC, 0.1% SDS at room temperature and then twice for 30 min with 1ϫ SSC, 0.1% SDS at 65°C. The hybridization signal was recorded by autoradiography. RNA amounts were standardized by hybridization to an 18 S rRNA probe at 60°C.
Construction of Yeast Expression Vector-The coexpression plasmid pAMR2 for rat CYP1A1 and yeast NADPH-P450 reductase has been constructed previously (24) . The coexpression vector pGYR for P450 and yeast NADPH-P450 reductase, constructed in a similar manner, was kindly provided by Dr. Y. Yabusaki of Sumitomo Chemical Co., Ltd. The resulting vector contained a glyceraldehyde-3-phosphate dehydrogenase promoter and terminator (25) 
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was further modified to contain an NcoI site and an XhoI site to construct pGYR-NX.
Full-length CYP719 cDNA was amplified by PCR using singlestranded cDNAs synthesized from 1.3 g of total RNA of cultured C. japonica cells with oligo(dT) primer and SuperScript II RNase H reverse transcriptase (Invitrogen). The following primers were used for CYP719: the forward primer (5Ј-ATATCTGCAGCCATGGAGAT-GAATCCACTGC-3Ј) was designed to introduce a PstI site (CTGCAG) and an NcoI site (underlined, CCATGG) at the ATG start codon, and the reverse primer (5Ј-ATCCAACTCAAACATTTCTACCAGCG-3Ј) was designed to contain a stop codon (underlined).
PCR products for CYP719 were digested with PstI and introduced into pBluescript SKϪ with PstI and EcoRV sites. The resulting plasmid was then digested with NcoI and XhoI, which produced CYP719 coding fragment. This coding fragment was ligated into the NcoI/XhoI site of pGYR-NX to generate yeast CYP719 expression vector, pGN-CYP719. The resulting construct was completely sequenced to confirm that no changes were introduced by subcloning processes.
Heterologous Expression of CYP719 in Yeast-The expression plasmid for CYP719 (pGN-CYP719) was transformed into yeast strain AH22 (26) by the LiCl method (27) . These recombinant yeast cells were cultivated in concentrated SD medium at 30°C, 220 rpm (28) . To suppress the expression of endogenous P450s in yeast, cultivation was carried out under aerobic conditions (29) . Yeast microsomal fractions were prepared as described previously (26) with the following modification: a Dounce glass homogenizer was used to fracture yeasts instead of a sonicator, and the microsomal fractions that were finally obtained were suspended in 50 mM HEPES/NaOH (pH 7.6), the same buffer as in enzyme assay mixture, instead of 100 mM potassium phosphate buffer (pH 7.4).
Measurement of P450 Hemoprotein-The reduced CO-difference spectra were measured with a Shimadzu UV-2200 spectrophotometer (Kyoto, Japan) as described previously (26) . The P450 hemoprotein content in the microsomal fraction was determined from the reduced CO-difference spectrum using a difference of 91 mM Ϫ1 cm Ϫ1 between the extinction coefficients at 446 and 490 nm (30) .
Assay of Enzymatic Activity-CYP719 activity was determined by high performance liquid chromatography (HPLC) and liquid chromatography-mass spectroscopy (LC-MS). The standard enzyme reaction mixture consisted of 50 mM HEPES/NaOH (pH 7.6), 500 M NADPH, 5 M substrate, and the enzyme preparation. The assay mixture was incubated at 30°C for 30 min, except for the determination of kinetic parameters (for 5-10 min), and then the reaction was terminated by the addition of trichloroacetic acid (final concentration 2%) and methanol (final concentration 15%). After protein precipitation, the reaction product was determined quantitatively by reversed-phase HPLC with a Shimadzu LC-10A system: column, TSKgel ODS-80TM (4.6 ϫ 250 mm; Tosoh); solvent system, acetonitrile/H 2 O/acetic acid (35:64:1); flow rate, 0.8 ml/min; detection, absorbance measurement at 280 nm with a SPD6A photodiode array detector. Product formation was confirmed by LC-MS (LCMS-2010, Shimadzu) under the same conditions as in HPLC analysis except for the flow rate (0.5 ml/min).
Data were fitted to the Michaelis-Menten equation by the nonlinear least-squares iterative method using KaleidaGraph (Synergy Software, Reading, PA). Three sets of the kinetic parameters were obtained from three independent experiments and then were simply averaged to yield the final estimates. The final estimates were shown with the standard error for the three sets.
Other Methods-The amounts of (S)-THC and (S)-THB were estimated by HPLC analysis using the calibration curve of (S)-scoulerine (mol versus peak area) and the absorption ratio of (S)-scoulerine, (S)-THC, and (S)-THB at 280 nm (1.00:0.89:1.20). Protein concentration was determined according to Bradford (31) with bovine serum albumin as a standard.
RESULTS
Isolation of Cytochrome P450 cDNAs-Cytochrome P450 (P450) cDNA fragments, amplified from a cDNA library, were prepared from high berberine-producing cultured C. japonica 156-1 cells using degenerated primers designed from the conserved region of eukaryotic P450s (18) . After nested PCR, clear PCR products at about 200 bp were obtained. Sequence analysis of the fragments subcloned into pBluescript II SKϪ showed that these PCR products contained two different cDNA sequences, both of which were homologous to plant P450s.
Thus, we used the PCR products as a probe to screen C. japonica P450s from the cDNA library.
From ϳ200,000 plaque-forming units, 40 positive plaques were isolated, and their cDNAs were subcloned into pBluescript SKϪ by in vivo excision. PCR amplification of cDNAs in pBluescript SKϪ revealed that cDNAs consisted of two inserts of different lengths, ϳ1.7 and 0.8 kb. Preliminary sequence analysis of the 3Ј-untranslated region of all cDNAs showed that the ϳ1.7-kb and ϳ0.8-kb fragments were basically distinguishable, and these were designated CYPCJA and CYPCJB, respectively.
Nucleotide Sequences and Predicted Amino Acid SequencesThe two longest cDNA clones, which represented CYPCJA and CYPCJB, were selected and sequenced. A representative CYPCJA clone carried 1,671 nucleotides with an open reading frame that encoded 488 amino acids (DDBJ/GenBank TM / EMBL accession number AB025030). The predicted amino acid sequence had motifs characteristic of eukaryotic P450s and was sufficient to encode a full-length of P450 (Fig. 2) .
On the other hand, the sequenced CYPCJB had only 806 nucleotides and encoded a partial 3Ј-fragment of P450 cDNA. To isolate a full-length clone of CYPCJB, 5Ј-rapid amplification of cDNA end was conducted. Based on the sequence of the 5Ј-end obtained, full-length cDNA was amplified, and the nucleotide sequence was determined. Full-length CYPCJB contained 1,658 nucleotides with an open reading frame for 492 amino acids, which encoded a characteristic plant P450, indicating that it encoded a full-length cDNA of P450 (DDBJ/ GenBank TM /EMBL accession number AB026122) (Fig. 2) . The amino acid sequence of CYPCJA is quite similar (68.4% identity) to that of CYP80B1, (S)-N-methylcoclaurine-3Ј-hydroxylase in reticuline biosynthesis, from the California poppy, E. californica (5) , suggesting that it is an ortholog of C. japonica (Fig. 3) . On the other hand, the amino acid sequence of full-length CYPCJB is not particularly similar to any known P450, suggesting that it may belong in a novel P450 family FIG. 4 . RNA blot analysis of CYP719 expression in cultured cells and plant tissues of C. japonica. Total RNA (10 g) prepared from cultured C. japonica cells and C. japonica plant tissues (leaf, petiole, rhizome, and root) were denatured, electrophoresed, transferred to a nylon membrane, and hybridized with radiolabeled CYP719, CYP80B2, 6-OMT, and 4Ј-OMT cDNA fragment probes as described under "Experimental Procedures." (Fig. 3) . These predicted amino acid sequences were classified by the P450 nomenclature committee, 2 and CYPCJA and CYPCJB were named CYP80B2 and CYP719, respectively.
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Although the identity between the amino acid sequences of CYP80B2 and CYP719 was rather low (23.5%), they had conserved eukaryotic P450 regions: a helix K region, an aromatic region, and a heme-binding region at the C-terminal end (Fig.  2) . In addition, their N-terminal regions contained hydrophobic domains corresponding to the membrane anchor sequences of microsomal P450 species, suggesting that CYP80B2 and CYP719 are localized in the endoplasmic reticulum. On the other hand, CYP719 did not have a conserved threonine (corresponding to Thr-252 of P450cam), which plays a significant role in oxygen-activation (32), but had serine instead (Ser-296). This substitution is not seen in most P450s but is found in a few species such as Zea mays CYP88A1 (GenBank TM accession number U32579) and Nicotiana tabacum CYP92A2 (GenBank TM accession number X95342). 
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FIG. 5. LC-MS analysis of CYP719 reaction product (A), authentic (R,S)-tetrahydroberberine (B), and vector control reaction (C). TIC, total ion chromatogram. (S)-THC and (R,S)-THB
could not be fragmented under our experimental conditions, and therefore their parent ions were detected. activity of CYP719 was unknown, we determined the expression of CYP719 in cultured C. japonica cells and C. japonica plant tissues (Fig. 4) . A previous study of SMT expression indicated that cultured C. japonica cells with high berberine productivity showed a high expression of SMT, and moderate expression was seen in the root, which is the primary biosynthetic organ in C. japonica (33) . When the cDNA expression for CYP719 was compared with three biosynthetic genes (CYP80B2, 6-OMT, and 4Ј-OMT), all four genes showed similar expression profiles: very high expression in cultured cells, moderate expression in root, and scarce expression in other tissues. This result indicated that CYP719 is likely involved in berberine biosynthesis.
Heterologous Expression of CYP719 in Yeast and Its Activity-To confirm the function of CYP719, it was expressed heterologously in yeast. Yeast expression plasmid for CYP719 was constructed and transformed to yeast AH22. Because CYP719 had a putative endoplasmic reticulum-localizing signal, microsomal fractions were prepared from recombinant yeast cells, and its enzymatic activity was determined using LC-MS analysis.
Microsomal fractions of CYP719-expressing yeast showed canadine synthase activity, i.e. the formation of (S)-THB from (S)-THC was detected (Fig. 5) . This result clearly indicated that CYP719 was a methylenedioxy bridge-forming enzyme, which produces (S)-THB from (S)-THC in berberine biosynthesis. Because the enzymologic properties of CYP719 were not clear, we used this recombinant CYP719 for further analysis.
Enzymatic Characterization of CYP719 -First, the P450 nature of CYP719 was confirmed using reduced CO-difference spectra (Fig. 6) . A clear peak at 446 nm showed that CYP719 was expressed as an active P450. This spectrum also showed that a recombinant microsomal fraction contained CYP719 at 48.8 pmol/mg of protein. CYP719 activity was also dependent on NADPH and oxygen; the absence of NADPH or the removal of O 2 by the glucose/glucoseoxidase/catalase system (8) clearly inactivated the CYP719 activity for (S)-THC (Table I) . A synthetic fungicide, ketoconazole, which is a typical P450 inhibitor that interacts with the prosthetic heme group (34), also inhibited methylenedioxy bridge-forming activity (Table II) .
Substrate Specificity and Affinity of CYP719 -To examine the possibility of whether CYP719 could catalyze three different steps in berberine/coptisine biosynthesis, the substrate specificity of CYP719 was examined using LC-MS analysis in comparison with (S)-THC as a reference substrate. When seven structurally related substrates were used as the substrate (Fig.  7) , none was converted by CYP719 to the corresponding products with a methylenedioxy bridge, indicating that CYP719 had high substrate specificity.
Next, the substrate affinity of CYP719 was determined using HPLC analysis with (S)-THC as the substrate. When the substrate concentration was varied, the reaction followed Michaelis-Menten-type kinetics. The kinetic parameters K m and V max values were estimated at 0.269 Ϯ 0.003 M and 1.86 Ϯ 0.10 pmol of product/min/pmol of P450, respectively (Fig. 8) .
Inhibition of CYP719 Activity by Structurally Related Isoquinoline Alkaloids-To understand the regulation of berberine biosynthesis, the effects of various structurally related isoquinoline alkaloids on CYP719 activity were examined. Interestingly, (S)-scoulerine, a precursor of (S)-THC, inhibited the methylenedioxy bridge-forming activity of CYP719 in a competitive manner with a K i value of 12.1 Ϯ 2.2 M, whereas it was not a substrate for CYP719 (data not shown). Further, columbamine, an oxidized form of (S)-THC, also inhibited CYP719 activity and was not a substrate for CYP719 (Table II) . Berberine, the end product of the berberine biosynthetic pathway, did not inhibit the methylenedioxy bridge-forming activity of CYP719.
DISCUSSION
In this study, we isolated two full-length cytochrome P450 cDNAs (CYP80B2 and CYP719) from high berberine-producing cultured C. japonica cells. Structural analysis and heterologous FIG. 6 . Reduced CO-difference spectra of CYP719 heterologously expressed in yeast. Reduced CO-difference spectra were recorded using microsomal fractions of recombinant yeast (1 mg protein/ ml). Dotted line, the spectrum recorded with the microsomal fraction from control yeast, transformed with a void plasmid. Solid line, the microsomal fraction from yeast expressing CYP719. was an ortholog of CYP80B1, which is (S)-N-methylcoclaurine-3Ј-hydroxylase isolated from the California poppy ( Fig. 2) 
(5).
On the other hand, CYP719 was placed in a new P450 family and showed methylenedioxy bridge-forming activity for (S)-THC as a substrate, i.e. canadine synthase activity, which converts (S)-THC to (S)-THB (Fig. 5) . CYP719 is the first P450 to be identified as a methylenedioxy bridge-forming enzyme. Methylenedioxy bridge formation, which is the cyclization of an ortho-methoxyphenol, is commonly found in many secondary metabolites, including lignans. This reaction is difficult to mimic in organic chemistry. A previous study showed that the formation of two methylenedioxy bridges in (S)-stylopine biosynthesis in California poppy was catalyzed by P450s (8) . These P450s ((S)-cheilanthifoline synthase ((S)-CHS) and (S)-stylopine synthase catalyze the reaction of (S)-scoulerine via (S)-cheilanthifoline to (S)-stylopine. These two steps are also found in C. japonica cells to produce coptisine (Fig. 1) . Whereas we had speculated that a methylenedioxy bridge-forming enzyme would catalyze all conversions from (S)-scoulerine to (S)-stylopine as well as from (S)-THC to (S)-THB, recombinant C. japonica CYP719 did not convert (S)-scoulerine to (S)-cheilanthifoline, indicating that there are likely other methylenedioxy bridge-forming enzyme(s) in coptisine biosynthesis. On the other hand, CYP719 might function as (S)-stylopine synthase. When (S)-cheilanthifoline or (S)-CHS is available, we will examine this possibility regarding CYP719.
Analysis of the substrate specificity of CYP719 indicated that berberine was produced from (S)-THC via (S)-THB and not via columbamine in C. japonica. Interestingly, columbamine slightly inhibited the methylenedioxy bridge-forming reaction of CYP719. Our study as well as a previous report showed that methylenedioxy bridge-forming enzymes such as CYP719, (S)-CHS, and (S)-stylopine synthase have low K m values (0.269, 0.9, and 0.4 M, respectively) for their corresponding substrates and high substrate specificities (8) , indicating that their substrate recognition is very strict and controls the biosynthetic pathway.
(S)-Scoulerine was not used as a substrate but showed inhibitory activity for CYP719 with a K i value of 12.1 M. The SMT reaction has been shown to be inhibited by the endproduct, berberine (12) . Modification of the berberine/coptisine ratio by the ectopic expression of SMT in C. japonica cells suggested that the balance of SMT and (S)-CHS regulates metabolic flow (35) . The accumulation of (S)-scoulerine induced by berberine may inhibit CYP719 activity and regulate the flow of substrate to coptisine in vivo.
Along with the dynamic regulation of secondary metabolism, the evolution of these divergent P450s is an interesting subject. (S)-CHS catalyzes the cyclization of an ortho-methoxyphenol of (S)-scoulerine in ring D (9,10-position), but not in ring A (2,3-position) (8) . On the other hand, CYP719 catalyzes the cyclization of an ortho-methoxyphenol of (S)-THC in ring A (2,3-position) but not ring D (9,10-position). Despite this difference, CYP719 and (S)-CHS recognize their own substrates based solely on whether or not (S)-THC has a 9-methoxy moiety. It is interesting that (S)-scoulerine was inhibitory for CYP719, whereas the K i value (12.1 M) was about 45 times higher than the K m value (0.269 M) for (S)-THC. CYP719 and (S)-CHS might have a similar ancestral origin.
Isolation of the remaining methylenedioxy bridge-forming enzyme cDNAs in coptisine biosynthesis will promote our understanding of P450 evolution in the isoquinoline alkaloid biosynthetic pathway. Recently, we isolated the cDNA of S-adenosyl-L-methionine:columbamine O-methyltransferase using an expressed sequence tag library prepared from cultured C. japonica cells (36) , whereas the biosynthetic activities of palmatine and other berberine-related alkaloids were relatively low in our cultured C. japonica cells. This success suggests that our expressed sequence tag library could be useful for isolating other isoquinoline biosynthetic enzymes including methylenedioxy bridge-forming P450(s) in coptisine biosynthesis. Further characterization has identified some expressed sequence tag clones, which showed some sequence similarity to plant P450 cDNA sequences different from those for CYP719 and CYP80B2. The isolation of full-length P450 cDNAs and their further characterization should add to our understanding of the structure/function relationship and evolution of P450s in isoquinoline alkaloid biosynthesis. FIG. 8 . The effect of (S)-tetrahydrocolumbamine concentrations on the methylenedioxy bridge-forming activity of CYP719. Methylenedioxy bridge-forming activity was measured using the microsomal fraction of CYP719 recombinant yeast as described under "Experimental Procedures." Three independent experiments with triplicate measurements were performed. In each experiment, data were fitted to the Michaelis-Menten equation by the nonlinear least-squares iterative method using KaleidaGraph (Synergy Software). The plot obtained from one set of exemplary data was shown.
